Biomarkers in ctDNA "could detect right at the start of treatment women whose cancers were most likely to develop resistance quickly to palbociclib". Nicholas Turner, Institute of Cancer Research.
Medscape News UK
Original Article: Liquid Biopsies Predict Early ER+ Breast Cancer Progression